Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Generation of reactive oxygen species (ROS) via the photodynamic therapy mechanism refers to a therapeutic process in which a photosensitizing chemical is administered and accumulates in tissues of interest (such as tumors). Upon irradiation with a specific wavelength of light, the photosensitizer transitions to an excited state and transfers energy to molecular oxygen, forming cytotoxic ROS such as singlet oxygen (^1O_2), superoxide, and hydroxyl radicals. These highly reactive species induce oxidative stress, directly causing cancer cell death (via apoptosis and necrosis), damaging tumor vasculature, and can enhance immune-mediated responses against tumor cells. This mechanism is the core of photodynamic therapy's anticancer effects but is not itself a molecular drug target, receptor, or protein[1][4][7][8].
Light-activated photosensitizers generate ROS (such as singlet oxygen, superoxide, hydroxyl radicals) in the presence of oxygen, which mediate cytotoxic effects on cells[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation via photodynamic therapy mechanism.